|By Marketwired .||
|June 12, 2014 04:01 PM EDT||
TORONTO, ONTARIO -- (Marketwired) -- 06/12/14 -- BioSyent Inc. ("BioSyent") (TSX VENTURE: RX) is pleased to announce that Canadian Business and PROFIT has ranked BioSyent as one of Canada's Fastest-Growing Companies in the just released 2014 rankings. Published in the July issue of Canadian Business and online at PROFITguide.com, the PROFIT 500 ranks Canadian businesses by their revenue growth over five years. Based upon a five year revenue (2008-2013) growth rate of 608%, BioSyent ranked 104 on the PROFIT 500 list. This is the second consecutive year that BioSyent has been named to the Profit 500 list and marks a significant increase in 5 year growth rate, from 355% on last year's list to 608% on this year's list.
For a direct market quote (15 minutes delay) for the TSX Venture Exchange and other Company financial information please visit www.tmxmoney.com.
About BioSyent Inc.
Listed on the Toronto Venture Exchange under the trading symbol "RX", BioSyent is a profitable growth oriented specialty pharmaceutical company which searches the globe to in-license or acquire innovative pharmaceutical products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients and supporting the healthcare professionals that treat them.
Once a product of interest has been found, BioSyent then acquires the exclusive rights to the product and manages it through the Canadian governmental regulatory approval process. Once approved, BioSyent markets the product throughout Canada.
At the date of this press release the Company had 13,801,195 shares issued and outstanding.
This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be materially different from the forward-looking information or statements. Potential risks may include, but are not limited to, those associated with clinical trials, product development, future revenue, operations, profitability and obtaining regulatory approvals.
The TSX Venture Exchange assumes no responsibility for the accuracy of this release and neither approves nor disapproves of the same.
Jul. 27, 2016 10:30 PM EDT Reads: 1,398
Jul. 27, 2016 10:30 PM EDT Reads: 2,008
Jul. 27, 2016 10:30 PM EDT Reads: 1,137
Jul. 27, 2016 10:15 PM EDT Reads: 1,397
Jul. 27, 2016 10:00 PM EDT Reads: 2,649
Jul. 27, 2016 09:45 PM EDT Reads: 1,992
Jul. 27, 2016 09:45 PM EDT Reads: 2,163
Jul. 27, 2016 09:30 PM EDT Reads: 268
Jul. 27, 2016 08:00 PM EDT Reads: 2,027
Jul. 27, 2016 07:30 PM EDT Reads: 1,084
Jul. 27, 2016 06:45 PM EDT Reads: 2,058
Jul. 27, 2016 06:45 PM EDT Reads: 1,161
Jul. 27, 2016 06:00 PM EDT Reads: 1,678
Jul. 27, 2016 05:45 PM EDT Reads: 872
A critical component of any IoT project is what to do with all the data being generated. This data needs to be captured, processed, structured, and stored in a way to facilitate different kinds of queries. Traditional data warehouse and analytical systems are mature technologies that can be used to handle certain kinds of queries, but they are not always well suited to many problems, particularly when there is a need for real-time insights.
Jul. 27, 2016 04:30 PM EDT Reads: 1,864